Novartis will close MorphoSys's factories in Germany and the USA.

According to Reuters on December 19, the Swiss pharmaceutical group Novartis announced on Thursday that it will close the German Biotechnology company MorphoSys's factories in Germany and the USA, acquired earlier this year, affecting approximately 330 positions. A company spokesperson stated that the plan is to exit the factories in Munich and Boston by the end of 2025 and to consolidate all portfolio activities into Novartis.

Gelonghui Finance21:25

Market Chatter: Novartis to Close MorphoSys Sites, Affecting 330 Jobs

MT Newswires20:47

Novartis AG (NOVN) Gets a Sell From Barclays

TipRanks18:45 · Ratings

The prospects of European Medical Care stocks are complex, with USA policies and new drug trial results being the key factors.

After falling from a high position in the last few months of 2024, European Medical Care stocks face the risks of US politics and the results of high-risk new drug trials in the new year.

Zhitong Finance14:48

CA Governor Newsom Proclaimed State Of Emergency To Further Enhance State's Preparedness And Accelerate The Bird Flu Cross-Agency Response Efforts

Benzinga03:45

CDC Confirms First Severe Case Of H5N1 Bird Flu In U.S. On December 13; Patient Hospitalized With Severe Case Of Avian Influenza A Virus Infection In Louisiana

Benzinga00:08